Daniela Krepper
YOU?
Author Swipe
View article: What’s missing in patient-reported outcome reporting? A scoping review and aggregated trial-level analysis of completion rates in oncology randomized controlled trials
What’s missing in patient-reported outcome reporting? A scoping review and aggregated trial-level analysis of completion rates in oncology randomized controlled trials Open
PRO completion rates in cancer RCTs remain challenging as they vary across settings, particularly beyond baseline, and reporting on missing data is often inadequate. These findings highlight the need for improved reporting and greater prio…
View article: A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials
A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials Open
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on prede…
View article: A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials
A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials Open
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on prede…
View article: Quality of Patient‐Reported Outcomes in Multiple Myeloma Randomized Controlled Trial Protocols and Publications According to the <scp>SPIRIT</scp> ‐ <scp>PRO</scp> and <scp>CONSORT</scp> ‐ <scp>PRO guidelines</scp> : A Systematic Review
Quality of Patient‐Reported Outcomes in Multiple Myeloma Randomized Controlled Trial Protocols and Publications According to the <span>SPIRIT</span> ‐ <span>PRO</span> and <span>CONSORT</span> ‐ <span>PRO guidelines</span> : A Systematic Review Open
Background Patient‐reported outcomes (PROs) are now frequently incorporated into multiple myeloma (MM) randomized controlled trials (RCTs) to help inform clinical decision making. Although the quality of PRO components in cancer RCT protoc…
View article: Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping review
Exploring patient-reported outcomes and morbidity burden of patients with VEXAS syndrome: a scoping review Open
This work was supported by AIRC5×1000 call "Metastatic disease: the key unmet need in oncology" to MYNERVA project, #21267 Myeloid Neoplasms Research Venture AIRC. Detailed description is available at http://www.progettoagimm.it.
View article: Lack of precision in the reporting of sex and gender in cancer clinical trials with a PRO endpoint: a systematic review
Lack of precision in the reporting of sex and gender in cancer clinical trials with a PRO endpoint: a systematic review Open
Background Sex and gender are acknowledged as pivotal variables in clinical research. However, the differences between the concepts are frequently neglected in medical research, resulting in limited generalizability of research findings an…
View article: Cancer‐Specificity of Sex Differences and Sex‐Specific Impact of Sociodemographic Characteristics in Cancer Patients' Health‐Related Quality of Life: A Cross‐Sectional Study
Cancer‐Specificity of Sex Differences and Sex‐Specific Impact of Sociodemographic Characteristics in Cancer Patients' Health‐Related Quality of Life: A Cross‐Sectional Study Open
Background Health‐related quality of life (HRQoL) is a multi‐dimensional concept commonly assessed in patient‐centered research on the impact of cancer and its treatment. Apart from disease and treatment characteristics, HRQoL is also infl…
View article: Machine learning models including patient-reported outcome data in oncology: a systematic literature review and analysis of their reporting quality
Machine learning models including patient-reported outcome data in oncology: a systematic literature review and analysis of their reporting quality Open
Purpose To critically examine the current state of machine learning (ML) models including patient-reported outcome measure (PROM) scores in cancer research, by investigating the reporting quality of currently available studies and proposin…
View article: Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study
Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study Open
PURPOSE Health-related quality of life (HRQoL) is now an important goal of therapy for patients with chronic myeloid leukemia (CML). However, there is paucity of data for patients living in low-income countries (LICs) and on factors associ…
View article: Data collection methods for patient-reported outcome measures in cancer randomised controlled trials: a protocol for a rapid scoping review
Data collection methods for patient-reported outcome measures in cancer randomised controlled trials: a protocol for a rapid scoping review Open
Background There are different modes and ways to assess patient-reported outcomes (PROs) in clinical trials. However, there is little systematic information on how often different modes of assessment (MOA) are used in cancer clinical trial…
View article: Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review
Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review Open
International efforts to raise awareness of the importance of accurately reporting state-of-the-art handling of missing PRO data are not yet fully reflected in the current literature of breast cancer RCTs.